Cartesian Therapeutics Inc - RNAC - stock price prediction, stock price target, analyst ratings from 8 analysts

Cartesian Therapeutics Inc has a share price target of US$ 36, revenue growth forecast of -91.1%, and profit growth estimate of -12.8% for FY25, based on top 8 analyst calls.